Patients who are treated through the Thoracic Oncology Program at Smilow Cancer Hospital benefit from specialized expertise of our clinicians and state-of-the-art surgery and therapies for their disease. Long-term survival for patients treated for non-small cell lung cancer exceeds national benchmarks for each stage of the disease.
The Thoracic Oncology Program has specifically designed quality metrics to ensure each patient receives exceptional care and that their disease is appropriately managed throughout the staging and treatment process. TOP is currently at or above the goals that were established.
Yale Cancer Center and Smilow Cancer Hospital continually monitor patient satisfaction and responses through the Press Ganey patient surveys. The Thoracic Oncology Program consistently ranks highly in these surveys for physician and nursing care.